Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HY209 Gel in Mild to Moderate Atopic Dermatitis
NCT06024499Phase 2Completed
- Sponsor
- Shaperon
- Start
- Mar 2024
- Primary completion
- Apr 2026
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of hy209gel in atopic dermatitis (AD), sponsored by Shaperon. Started Mar 2024; status: completed.
02
Drugs
hy209gel
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06024499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06024499.